Skip to main content
OpenTrials

Clinical trial condition

Treatment-naїve Mantle Cell Lymphoma

Explore clinical trials studying Treatment-naїve Mantle Cell Lymphoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Treatment-naїve Mantle Cell Lymphoma trial results

Completed

A Randomized, Open-label, Multi-center, Phase III Study of Orelabrutinib in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) vs. R-CHOP Alone in Patients With Treatment-naїve Mantle Cell Lymphoma

NCT05051891

Conditions
Treatment-naїve Mantle Cell Lymphoma
Locations
  • Anhui Province Cancer Hospital Hefei, Anhui, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Tumor in Hunan Province Hunan, Changsha, China
  • The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China
View all 22 locations
View Trial Details